Psychiatry Consortium funds project investigating new schizophrenia treatments by Lucy Parsons | Jan 25, 2021 | News | 0 Project will see the University of Oxford partner with the Earlham Institute, Biogen and Boehringer Ingelheim Read More
Medicines Discovery Catapult, MQ, Alzheimer’s Research UK form alliance by Anna Smith | Jun 20, 2019 | News | 0 The partnership will focus on identifying and validating novel drug targets for unmet therapeutic needs for psychiatric symptoms affecting people with mental health conditions Read More